MLLT3
MOLECULAR TARGETMLLT3 super elongation complex subunit
MLLT3 (MLLT3 super elongation complex subunit) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting MLLT3
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Perphenazine | 1.39 | 3 |
| 2 | Methylene Blue | 1.10 | 2 |
| 3 | Chlorhexidine | 1.10 | 2 |
| 4 | Nisoldipine | 1.10 | 2 |
| 5 | Thioridazine | 1.10 | 2 |
| 6 | Biotin | 0.69 | 1 |
| 7 | chlorprothixene hydrochloride | 0.69 | 1 |
| 8 | Ethidium | 0.69 | 1 |
| 9 | Nitrofurantoin | 0.69 | 1 |
| 10 | Nortriptyline | 0.69 | 1 |
About MLLT3 as a Drug Target
MLLT3 (MLLT3 super elongation complex subunit) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented MLLT3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
MLLT3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.